IQV
IQVIA Holdings Inc.
Diagnostics & Research · Healthcare · United States
241.52
close · 2026-08-13
value
80
cheaper than peers80
quality
33
stronger fundamentals33
ranked against
Diagnostics & Research
value
quality
28 peers
Value inputs
| measure | company | vs peers |
| forward P/E | 16.72× | 92 |
| price to sales | 2.45× | 80 |
| EV to EBITDA | 16.56× | 79 |
| price to book | 6.44× | 40 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 22.5% | 79 |
| operating margin | 13.6% | 57 |
| revenue growth | 8.4% | 27 |
| debt to equity | 253.5% | 10 |
4 of 4 measures available
Facts
| market cap | $40B |
| free cash flow | $2.28B |
| employees | 93,000 |
| first trade | 2013-05-09 |
| next earnings | 2026-07-28 |
| fundamentals updated | 2026-07-29 |